Andros Pharmaceuticals Co.,Ltd (TPEX:6917)

Market Cap	805.90M
Revenue	n/a
Net Income	n/a
Shares Out	44.77M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	93,260
Average Volume	58,170
Open	18.10
Previous Close	18.00
Day's Range	17.65 - 18.10
52-Week Range	13.85 - 21.85
Beta	-0.77
RSI	64.45
Earnings Date	n/a

About TPEX:6917

Andros Pharmaceuticals Co.,Ltd, a biopharmaceutical company, engages in developing novel drug delivery platform technologies. The company develops APC101, a fast-drying, film-forming, and meter-dosed spray, which is in Phase IIa clinical trial to treat pain associated with post-herpetic neuralgia; APC201, a novel dosage form of topical anesthetic that is in Phase I/II clinical trial for treatment of Osteoarthritis; and siRNA, an anti-sense oligonucleotide and DNA candidate. Its preclinical phase products are APC310 and APC501 for anesthesia to ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6917